Single Cell Multiomics Market Expected to Reach $15,261.19 Million by 2030

Posted on Nov 24 2022 5:51 AM

"The growth of the global single cell multiomics market is attributed to increase in prevalence of genetic disorders and technological advancements in single-cell analysis. Moreover, increase in adoption of personalized medicine for screening and diagnostics of genetic disorders and rise in healthcare expenditure is expected to further drive the market growth during the forecast years. "

Single cell multiomics market was valued at $2,175 million in 2020, and is projected to reach $15,261.19 million by 2030 registering a CAGR of 21.4% from 2021 to 2030. Single cell multiomics analysis assimilates multiple data sets from the genome, epigenome, transcriptome, proteome, providing a unique chance to uncover novel biological processes. Integrated approaches combine individual omics data in a sequential or simultaneous manner to understand the interplay of molecules. Furthermore, they help in assessing the flow of information from one omics level to the other, and thus help in bridging the gap from genotype to phenotype. The single cell multi omics measures multiple types of the molecule from single cell of the same individual.

List of Key Players

10x Genomics, Inc., Becton, Dickinson and Company, Berkeley Lights Inc., BGI Genomics Co. Ltd, Bio Rad Laboratories, Inc., Danaher Corporation (Cytiva Life Sciences), Dolomite Bio, Epicypher Inc., Fluidigm Corporation

Download Sample Report:

The single cell sequencing technology is divided into genotypic and phenotypic, which help to determine the mechanisms to govern diseases and health. Furthermore, applications of single cell multiomics primarily include oncology, cell biology, neurology, stem cell, and immunology. Single cell omics have great potential in deciphering virus biology and virus-host cell interactions, which acts as a powerful tool in virology that should be applied more often in future.

For instance, in June 2021, BGI Americas Corporation, a part of BGI Genomics Co. Ltd. announced a collaborative agreement with Champions Oncology to offer their respective customers end-to-end proteomics and multiomics solutions for oncology biomarker discovery and validation. Thus, such collaborations among the key players significantly propels the single cell multiomics market growth.

The single cell multiomics market growth is attributed to rise in technological advancements in single-cell analysis products. Furthermore, increasing adoption of personalized medicine for screening and diagnostics of genetic disorders and rising disposable income in emerging economies drive the growth of the single cell multiomics market.

However, high cost of single cell analysis and limited availability of large online data storage and analysis platforms are expected to restrain the growth of the market. Conversely, expansion into new research applications, such as single-cell metabolomics, and increase in collaborations & funding in the research of single cell multiomics are anticipated to provide lucrative growth opportunities for single cell multiomics market players.

On the basis of type, the single cell multiomics market is categorized into single cell genomics, single cell proteomics, single cell transcriptomics and single cell metabolomics. The single cell genomics segment generated maximum revenue in 2020, accounting $897.2 million. The single cell proteomics segment is expected to witness highest CAGR of 22.3% during the forecast period.

For Purchase inquiry:

By application, it is classified into oncology, cell biology, neurology, immunology and stem research. The oncology segment generated maximum revenue in 2020, accounting $763.17 million. The neurology segment is expected to witness highest CAGR of 24.5% during the forecast period.

Depending upon the technique, the single cell multiomics market is segmented into single-cell isolation & dispensing and single-cell analysis. The single-cell analysis segment generated maximum revenue in 2020, accounting $1,530.9 million. The single-cell isolation & dispensing segment is expected to witness highest CAGR of 22% during the forecast period.

By end user, it is further segmented into academic institutes, contract research organizations, and pharmaceutical & biotech companies. The academic institutes segment generated maximum revenue in 2020, accounting $1,475.97 million. The contract research organizations segment is expected to witness highest CAGR of 22.6% during the forecast period.

Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is projected to account for a major share of $1,030.95 the global single cell multiomics market during the forecast period. The market in the region is anticipated grow in future, owing to availability of developed healthcare infrastructure and continuous research activities for the development of advanced technologies in the region. Europe holds the second largest share and is expected to witness highest CAGR of 25.2% during the forecast period.


About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]